Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bioalpha Holdings BhdXKLS:0179 EBIT per Share is RM-0.02 as of Mar. 2026. The stock has 6 warning signs investors should review. Among 1,581 Consumer Packaged Goods companies, Bioalpha Holdings Bhd ranks worse than 50.16% on this metric.
Bioalpha Holdings Bhd's EBIT per Share for the
three
months ended in Mar. 2026 was RM-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was RM-0.02.
During the past 3 years, the average EBIT per Share Growth Rate was 6.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -10.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Bioalpha Holdings Bhd's EBIT per Share or its related term are showing as below:
XKLS:0179'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -115.4 Med: 6.8 Max: 100
Current: 6.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Bioalpha Holdings Bhd was 100.00% per year. The lowest was -115.40% per year. And the median was 6.80% per year.
XKLS:0179's 3-Year EBIT Growth Rate is ranked worse than 50.16% of 1581
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs XKLS:0179: 6.80
Bioalpha Holdings Bhd (XKLS:0179) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Bioalpha Holdings Bhd EBIT per Share Related Terms
Bioalpha Holdings Bhd EBIT per Share Historical Data
* Premium members only.
The historical data trend for Bioalpha Holdings Bhd's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioalpha Holdings Bhd (XKLS:0179) has a EBIT per Share of RM-0.02 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Bioalpha Holdings Bhd and its competitors. According to the industry distribution chart, Bioalpha Holdings Bhd ranks #793 out of 1581 companies in the Consumer Packaged Goods industry, placing it in the top 50.2%.
Is Bioalpha Holdings Bhd's EBIT per Share too high?
Bioalpha Holdings Bhd's current EBIT per Share is RM-0.02. Based on the distribution chart, Bioalpha Holdings Bhd ranks #793 out of 1581 companies in the Consumer Packaged Goods industry, which is below the industry midpoint.
How does Bioalpha Holdings Bhd's EBIT per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bioalpha Holdings Bhd ranks #793 out of 1581 companies for EBIT per Share. This places Bioalpha Holdings Bhd in the lower half of its industry. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Bioalpha Holdings Bhd and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioalpha Holdings Bhd's current EBIT per Share is RM-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioalpha Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Bioalpha Holdings Bhd (XKLS:0179) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.02 — trading 100% above its estimated fair value. The current EBIT per Share is RM-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Bioalpha Holdings Bhd (XKLS:0179), the current EBIT per Share is RM-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bioalpha Holdings Bhd is a nutraceutical and health supplement group in Malaysia, operates a multi-faceted value chain that includes agricultural development, research and development (R&D), and the manufacturing of functional food and supplement products on an Original Design Manufacturer (ODM) basis. The business operates in segments that include Trading, Manufacturing, Retail pharmacy, and Others. It generates maximum revenue from Manufacturing segment, which involves Research, development, manufacture, importer, exporter, distribution and trader of nutritional and health care products. Geographically, the company derives majority revenue from Malaysia, while it also has its presence in China and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0179 has been successfully added to your 
